Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Retinoblastoma 1Retinal Neoplasms 1Neoplasms 1Eye Neoplasms 1

Interventions

pembrolizumab 514Specimen Handling 382Carboplatin 372Magnetic Resonance Spectroscopy 333Cisplatin 327Nivolumab 303Cyclophosphamide 295Radiotherapy 255Paclitaxel 252Biopsy 235Gemcitabine 231Bevacizumab 212Dexamethasone 167durvalumab 162Oxaliplatin 160Capecitabine 155Rituximab 152Fluorouracil 148venetoclax 143Docetaxel 143atezolizumab 141Drug Therapy 140Etoposide 139Doxorubicin 131Ipilimumab 126Radiosurgery 118Prednisone 117Lenalidomide 117Leucovorin 111fludarabine 109

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Lasers × 1 year × Clear all
NCT06643884 2026-03-13

Suprachoroidal Administration in Subjects With Metastases to the Choroid

Aura Biosciences

Phase 2 Recruiting
24 enrolled

Eye Neoplasms, Neoplasms

NCT02866136 2025-11-24

RETINO2011

Institut Curie

Phase 2 Active not recruiting
133 enrolled
Other solid neoplasm

Retinoblastoma, Retinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡